Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors
AbstractA series of 22 donepezil analogues were synthesized through alkylation/benzylation and compared to donepezil and its 6-O-desmethyl adduct. All the compounds were found to be potent inhibitors of both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), two enzymes responsible for the hydrolysis of the neurotransmitter acetylcholine in Alzheimer’s disease patient brains. Many of them displayed lower inhibitory concentrations of EeAChE (IC50 = 0.016 ± 0.001 µM to 0.23 ± 0.03 µM) and EfBChE (IC50 = 0.11 ± 0.01 µM to 1.3 ± 0.2 µM) than donepezil. One of the better compounds was tested against HsAChE and was found to be even more active than donepezil and inhibited HsAChE better than EeAChE. The analogues with the aromatic substituents were generally more potent than the ones with aliphatic substituents. Five of the analogues also inhibited the action of β-secretase (BACE1) enzyme. View Full-Text
- Supplementary File 1:
PDF-Document (PDF, 38427 KB)
Share & Cite This Article
Green, K.D.; Fosso, M.Y.; Garneau-Tsodikova, S. Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors. Molecules 2018, 23, 3252.
Green KD, Fosso MY, Garneau-Tsodikova S. Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors. Molecules. 2018; 23(12):3252.Chicago/Turabian Style
Green, Keith D.; Fosso, Marina Y.; Garneau-Tsodikova, Sylvie. 2018. "Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors." Molecules 23, no. 12: 3252.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.